• to reduce the potential risk of major cardiovascular (heart and blood vessel) difficulties in Older people with form two diabetes and cardiovascular diseaseCalifornia biotech behemoth Amgen ditched programs for an experimental weight loss pill in May well but continues to be hoping to get a slice of the industry with MariTide, a regular monthly